Free Trial

Iofina (LON:IOF) Receives Buy Rating from Canaccord Genuity Group

Iofina logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Canaccord Genuity reaffirmed a Buy rating and set a GBX 45 price target, implying roughly a 42.9% upside from the current share price.
  • Shares were trading up 6.8% (opened GBX 31.50) with a market cap of £60.4m, a PE ratio of 12.6, and a 12‑month range of GBX 20–31.70.
  • Iofina is a vertically integrated iodine producer — the second-largest iodine producer in North America — operating Iofina Resources and Iofina Chemical.
  • MarketBeat previews the top five stocks to own by May 1st.

Iofina (LON:IOF - Get Free Report)'s stock had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group in a research note issued to investors on Wednesday,Digital Look reports. They presently have a GBX 45 price objective on the stock. Canaccord Genuity Group's price target suggests a potential upside of 42.86% from the stock's current price.

Iofina Trading Up 6.8%

Shares of LON:IOF opened at GBX 31.50 on Wednesday. Iofina has a 12-month low of GBX 20 and a 12-month high of GBX 31.70. The business's fifty day simple moving average is GBX 25.26 and its 200-day simple moving average is GBX 24.52. The company has a market capitalization of £60.44 million, a PE ratio of 12.60 and a beta of 0.53. The company has a current ratio of 2.43, a quick ratio of 1.56 and a debt-to-equity ratio of 14.85.

Iofina Company Profile

(Get Free Report)

Iofina plc is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products and derivatives. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities, Iofina Resources, and Iofina Chemical.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Iofina Right Now?

Before you consider Iofina, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Iofina wasn't on the list.

While Iofina currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines